Pharmafile Logo
Pharmafocus logo
Advanced Search

Endo

Showing 11 posts of 11 posts found.

abbvie_0

Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack

March 27, 2018
Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma

Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …

News
endo-international

Endo granted injunction to block blood pressure competitor

March 2, 2018
Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin

Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block  competitor …

News
headquarters_2013_endo

Endo pulls plug on Alabama plant, 875 jobs lost

July 25, 2017
Manufacturing and Production Endo, Qualitest, biotech, drugs, generics, pharma, pharmaceutical

Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of …

News
doc_writing

Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug

August 15, 2016
Sales and Marketing Endo, Endo International, abuse deterrent, opioid

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …

News
endo image

Endo lands a big fish with $8 billion Par Pharma deal

May 19, 2015
Sales and Marketing Endo, Valeant, par pharma

Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …

News

Pharma M&A trail continues as Pfizer buys slice of Dutch biotech

May 12, 2015
Sales and Marketing Endo, Pfizer, aspen, merger

Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …

News
Valeant image

Valeant sprints ahead of Endo to secure Salix

March 18, 2015
Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix

Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …

News
Salix image

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015
Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …

News
Endo image

Endo buys Auxilium for $2.6 billion

October 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum

Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …

News
Doctor and computer image

Perception of pharma online ‘negative’

October 25, 2012
Medical Communications, Sales and Marketing Digital Health Coalition, Endo, WEGO Health

Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …

News

Endo says Opana ER supply disruption will be temporary

February 28, 2012
Manufacturing and Production Endo, Novartis, Opana ER

Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023